| A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer (NCT00618826) | Barbara Ann Karmanos Cancer Institute | 2006-11-01 |
| Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00438204) | Barbara Ann Karmanos Cancer Institute | 2006-05-01 |
| Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors (NCT00369109) | Barbara Ann Karmanos Cancer Institute | 2006-02-01 |
| Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer (NCT00514215) | Barbara Ann Karmanos Cancer Institute | 2006-01-01 |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery (NCT00303901) | Barbara Ann Karmanos Cancer Institute | 2005-11-01 |
| Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00301808) | Barbara Ann Karmanos Cancer Institute | 2005-11-01 |
| Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy (NCT00305747) | Barbara Ann Karmanos Cancer Institute | 2005-08-01 |
| Studying Umbilical Cord Blood From African-American Donors (NCT00717535) | Barbara Ann Karmanos Cancer Institute | 2005-08-01 |
| Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant (NCT00288028) | Barbara Ann Karmanos Cancer Institute | 2005-07-01 |
| Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer (NCT00258466) | Barbara Ann Karmanos Cancer Institute | 2005-05-01 |
| Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT00376948) | Barbara Ann Karmanos Cancer Institute | 2005-05-01 |
| Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia (NCT00258245) | Barbara Ann Karmanos Cancer Institute | 2005-05-01 |
| Identification of Biomarkers for Early Detection of Pancreatic Cancer (NCT00897494) | Barbara Ann Karmanos Cancer Institute | 2005-02-01 |
| Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer (NCT00248560) | Barbara Ann Karmanos Cancer Institute | 2005-01-01 |
| Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer (NCT00897741) | Barbara Ann Karmanos Cancer Institute | 2004-12-01 |
| Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant (NCT00293384) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer (NCT00217581) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors (NCT00872677) | Barbara Ann Karmanos Cancer Institute | 2004-05-01 |
| Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma (NCT00244946) | Barbara Ann Karmanos Cancer Institute | 2004-03-01 |
| Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer (NCT00244933) | Barbara Ann Karmanos Cancer Institute | 2004-02-01 |
| Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo (NCT00258310) | Barbara Ann Karmanos Cancer Institute | 2003-12-01 |
| Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer (NCT00258284) | Barbara Ann Karmanos Cancer Institute | 2003-08-01 |
| Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia (NCT00066326) | Barbara Ann Karmanos Cancer Institute | 2003-06-01 |
| Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia (NCT00056004) | Barbara Ann Karmanos Cancer Institute | 2003-06-01 |
| Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer (NCT00068653) | Barbara Ann Karmanos Cancer Institute | 2003-06-01 |
| Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer (NCT00243048) | Barbara Ann Karmanos Cancer Institute | 2002-05-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors (NCT00052403) | Barbara Ann Karmanos Cancer Institute | 2002-02-01 |
| Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00248482) | Barbara Ann Karmanos Cancer Institute | 2002-02-01 |
| XK469 in Treating Patients With Advanced Solid Tumors (NCT00028548) | Barbara Ann Karmanos Cancer Institute | 2002-01-01 |
| Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer (NCT00258232) | Barbara Ann Karmanos Cancer Institute | 2002-01-01 |
| Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate (NCT00078923) | Barbara Ann Karmanos Cancer Institute | 2001-11-01 |
| Biological Therapy in Treating Women With Stage IV Breast Cancer (NCT00027807) | Barbara Ann Karmanos Cancer Institute | 2001-10-01 |
| Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer (NCT00030407) | Barbara Ann Karmanos Cancer Institute | 2001-10-01 |
| Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00030420) | Barbara Ann Karmanos Cancer Institute | 2001-10-01 |
| Proteases in Patients With Prostate Cancer That Has Spread to the Bone (NCT00899665) | Barbara Ann Karmanos Cancer Institute | 2001-07-01 |
| Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00016185) | Barbara Ann Karmanos Cancer Institute | 2001-03-01 |
| PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma (NCT00238329) | Barbara Ann Karmanos Cancer Institute | 2001-01-01 |
| Chemotherapy in Treating Patients With Advanced Kidney Cancer (NCT00011973) | Barbara Ann Karmanos Cancer Institute | 2000-12-01 |
| Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer (NCT00005027) | Barbara Ann Karmanos Cancer Institute | 2000-06-01 |
| Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer (NCT00004144) | Barbara Ann Karmanos Cancer Institute | 2000-05-01 |
| Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease (NCT00003936) | Barbara Ann Karmanos Cancer Institute | 1999-06-01 |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery (NCT00004003) | Barbara Ann Karmanos Cancer Institute | 1999-04-01 |
| Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy (NCT00003626) | Barbara Ann Karmanos Cancer Institute | 1998-10-01 |
| Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer (NCT00014573) | Barbara Ann Karmanos Cancer Institute | 1998-08-01 |
| Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia (NCT00003174) | Barbara Ann Karmanos Cancer Institute | 1998-05-01 |
| Fenretinide in Treating Patients With Solid Tumors (NCT00003250) | Barbara Ann Karmanos Cancer Institute | 1998-05-01 |
| Combination Chemotherapy In Treating Patients With Advanced Cancer (NCT00003925) | Barbara Ann Karmanos Cancer Institute | 1998-05-01 |
| Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome (NCT00003171) | Barbara Ann Karmanos Cancer Institute | 1998-05-01 |
| Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer (NCT00003220) | Barbara Ann Karmanos Cancer Institute | 1998-02-01 |
| Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma (NCT00004024) | Barbara Ann Karmanos Cancer Institute | 1997-06-01 |
| Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma (NCT00004022) | Barbara Ann Karmanos Cancer Institute | 1997-06-01 |
| KRN5500 in Treating Patients With Metastatic Solid Tumors (NCT00002923) | Barbara Ann Karmanos Cancer Institute | 1997-05-01 |
| Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma (NCT00002907) | Barbara Ann Karmanos Cancer Institute | 1997-01-01 |
| Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00002908) | Barbara Ann Karmanos Cancer Institute | 1996-12-01 |
| Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT00002656) | Barbara Ann Karmanos Cancer Institute | 1995-10-01 |
| Pyrazoloacridine in Treating Women With Metastatic Breast Cancer (NCT00002585) | Barbara Ann Karmanos Cancer Institute | 1994-02-01 |
| Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma (NCT00002552) | Barbara Ann Karmanos Cancer Institute | 1993-10-01 |
| Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome (NCT00002547) | Barbara Ann Karmanos Cancer Institute | 1987-08-01 |
| Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer (NCT00268255) | Barbara Ann Karmanos Cancer Institute | |